Jack Lawler

Jack Lawler is an experienced Executive with a strong background in the pharmaceutical industry. He has a proven track record in Global Clinical Development, Clinical Data Management, Biotechnology, Regulatory Affairs, and Project Management.

Jack Lawler studied at Malvern Prep, Rosemont College where he pursued BS in Business Management, West Chester University of Pennsylvania, and also completed studies in chemistry at Virginia Tech.

Currently, Jack Lawler holds the position of Vice President, Global Clinical Development Operations at Chemomab Therapeutics. He has previously worked in various roles including Principal Consultant at ClinDevPM Consulting, Vice President at Goldfinch Bio, Botanix Pharmaceuticals, Egalet Corporation, Executive Director at Egalet Corporation, Director at ViroPharma Incorporated (acquired by Shire), Trevena, Inc, Teva (formerly Cephalon), ClinDevPM Consulting, Clinical Research at ViroPharma Incorporated and Covance.

Jack's professional journey includes roles as a former Senior Transplant Coordinator at Gift of Life, Paramedic and Cardiopulmonary Technician at Paoli Hospital, Paramedic at Southern Chester County Medical Center, Emergency Services Dispatcher at the County of Chester, and Paramedic at Chester County Hospital.

With his extensive expertise and diverse experience in the pharmaceutical and healthcare sectors, Jack Lawler brings a wealth of knowledge to any organization he is a part of.